World News
Unapproved stem-cell therapies marketed to people with long COVID
The 38 businesses operated or facilitated access to 60 clinics, almost all in the United States and Mexico.
Read more.CDC weighs in on JN.1 COVID-19 variant developments
The estimated percentage of JN.1 viruses is very small—about 0.1%.
Read more.Study: Regardless of variant, half of long-COVID patients fail to improve after 18 months
The analysis included 806 patients who were infected with the wild-type strain, Alpha, Delta, or Omicron strain.
Read more.40% of oldest British Columbians hadn’t had COVID by July, leaving them more vulnerable
The researchers estimated 1 in 30 hospitalizations among newly infected adults aged 80 years and older.
Read more.US, global COVID-19 markers show declines
In a variant proportion update, the CDC said HV.1 has nudged ahead of EG.5.
Read more.